|
Market Closed -
Bombay S.E.
03:32:28 01/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 158.85 INR | +1.83% |
|
+3.49% | -6.61% |
| Market Cap | 50Cr 53.2L 45.89L 43.16L 39.32L 73.95L 74.35L 5.1Cr 1.99Cr 26Cr 2Cr 1.95Cr 85Cr | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 47Cr 49.78L 42.94L 40.39L 36.8L 69.2L 69.58L 4.78Cr 1.86Cr 24Cr 1.87Cr 1.83Cr 80Cr | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | +1.83% | ||
| 1 week | +3.49% | ||
| Current month | +1.83% | ||
| 1 month | -10.20% | ||
| 3 months | +6.68% | ||
| 6 months | +23.14% | ||
| Current year | -6.61% |
| 1 week | 150 |  | 159.95 |
| 1 month | 150 | | 188 |
| Current year | 100.1 | | 188 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 21/08/2016 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 07/10/2005 |
| Compliance Officer | - | 03/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 12/12/2005 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 07/10/2005 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 21/08/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.83% | +3.49% | -13.01% | -23.72% | 52.11L | |
| +0.31% | -5.98% | +57.77% | +108.20% | 1,03100Cr | |
| +1.65% | -0.56% | +52.53% | +69.24% | 64TCr | |
| +0.70% | -2.44% | +22.36% | +74.97% | 45TCr | |
| -1.50% | -6.18% | +33.50% | +33.50% | 35TCr | |
| +6.25% | +3.31% | +29.46% | +46.64% | 29TCr | |
| -0.07% | -1.22% | +1.46% | +12.19% | 25TCr | |
| +1.94% | -1.13% | +52.39% | +70.32% | 23TCr | |
| +0.51% | -1.79% | -18.09% | -53.86% | 20TCr | |
| +0.79% | +0.53% | +32.70% | +95.13% | 18TCr | |
| Average | +1.13% | -2.71% | +25.11% | +43.26% | 36.3TCr | |
| Weighted average by Cap. | +0.94% | -4.10% | +38.13% | +66.38% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 34Cr 35.81L 30.89L 29.06L 26.47L 49.78L 50.05L 3.44Cr 1.34Cr 17Cr 1.34Cr 1.32Cr 57Cr | 36Cr 37.64L 32.47L 30.54L 27.82L 52.32L 52.61L 3.61Cr 1.41Cr 18Cr 1.41Cr 1.38Cr 60Cr |
| Net income | 4.25Cr 4L 4L 4L 3L 6L 6L 42.92L 16.7L 2.16Cr 16.8L 16.43L 7.16Cr | 5.79Cr 6L 5L 5L 5L 8L 9L 58.51L 22.77L 2.94Cr 22.9L 22.41L 9.76Cr |
| Net Debt | -3.69Cr -4L -3L -3L -3L -5L -5L -37.27L -14.51L -1.88Cr -14.59L -14.27L -6.22Cr | -3.24Cr -3L -3L -3L -3L -5L -5L -32.74L -12.74L -1.65Cr -12.82L -12.54L -5.46Cr |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | ₹158.85 | +1.83% | 2,198 |
| 31/26/31 | ₹156.00 | 0.00% | 589 |
| 28/26/28 | ₹156.00 | +0.68% | 819 |
| 27/26/27 | ₹154.95 | +0.13% | 225 |
| 26/26/26 | ₹154.75 | +1.81% | 32 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
